173 related articles for article (PubMed ID: 23565820)
1. Systematic review: macrophage activation syndrome in inflammatory bowel disease.
Fries W; Cottone M; Cascio A
Aliment Pharmacol Ther; 2013 Jun; 37(11):1033-45. PubMed ID: 23565820
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.
Mazzola G; Macaluso FS; Adamoli L; Renna S; Cascio A; Orlando A
J Infect; 2017 May; 74(5):433-441. PubMed ID: 28263759
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome associated with griscelli syndrome type 2: case report and review of literature.
Sefsafi Z; Hasbaoui BE; Kili A; Agadr A; Khattab M
Pan Afr Med J; 2018; 29():75. PubMed ID: 29875956
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of Epstein-Barr Virus, Cytomegalovirus, and Polyomaviruses in Children with Inflammatory Bowel Disease.
Hradsky O; Copova I; Zarubova K; Durilova M; Nevoral J; Maminak M; Hubacek P; Bronsky J
Dig Dis Sci; 2015 Nov; 60(11):3399-407. PubMed ID: 26091801
[TBL] [Abstract][Full Text] [Related]
5. Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
Beaugerie L; Rahier JF; Kirchgesner J
Clin Gastroenterol Hepatol; 2020 May; 18(6):1324-1335.e2. PubMed ID: 32059920
[TBL] [Abstract][Full Text] [Related]
6. Infections in inflammatory bowel disease.
Rodríguez de Santiago E; Albillos Martínez A; López-Sanromán A
Med Clin (Barc); 2017 May; 148(9):415-423. PubMed ID: 28233560
[TBL] [Abstract][Full Text] [Related]
7. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study (.).
Thörn M; Rorsman F; Rönnblom A; Sangfelt P; Wanders A; Eriksson BM; Bondeson K
Scand J Gastroenterol; 2016 Sep; 51(9):1075-80. PubMed ID: 27142339
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'.
van Langenberg DR; Morrison G; Foley A; Buttigieg RJ; Gibson PR
J Crohns Colitis; 2011 Oct; 5(5):469-72. PubMed ID: 21939923
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory bowel diseases and lymphoma].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
[TBL] [Abstract][Full Text] [Related]
10. Intravascular large B-cell lymphoma associated with silicone breast implant, HLA-DRB1*11:01, and HLA-DQB1*03:01 manifesting as macrophage activation syndrome and with severe neurological symptoms: a case report.
Moling O; Piccin A; Tauber M; Marinello P; Canova M; Casini M; Negri G; Raffeiner B; Binazzi R; Gandini L; Vecchiato C; Rimenti G; Billio A
J Med Case Rep; 2016 Sep; 10(1):254. PubMed ID: 27634631
[TBL] [Abstract][Full Text] [Related]
11. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
[TBL] [Abstract][Full Text] [Related]
12. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
13. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience.
Bontà J; Zeitz J; Frei P; Biedermann L; Sulz MC; Vavricka SR; Scharl S; Fried M; Rogler G; Scharl M
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1329-34. PubMed ID: 27482785
[TBL] [Abstract][Full Text] [Related]
15. Updates on vaccinating the inflammatory bowel disease patient.
Zullow S; Farraye FA
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):229-239. PubMed ID: 30791761
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
Subramaniam K; D'Rozario J; Pavli P
J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome: why and what should a gastroenterologist know.
Jayakar BA; Hashkes PJ
J Clin Gastroenterol; 2011 Mar; 45(3):210-4. PubMed ID: 20921900
[TBL] [Abstract][Full Text] [Related]
18. [Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
Li CF; He XH; Kuang WY; Han TX; Zhou YF
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):806-11. PubMed ID: 17274865
[TBL] [Abstract][Full Text] [Related]
19. Vaccinating the inflammatory bowel disease patient.
Desalermos AP; Farraye FA; Wasan SK
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):91-102. PubMed ID: 25160668
[TBL] [Abstract][Full Text] [Related]
20. A practical guide to vaccinating the inflammatory bowel disease patient.
Wasan SK; Baker SE; Skolnik PR; Farraye FA
Am J Gastroenterol; 2010 Jun; 105(6):1231-8. PubMed ID: 20104218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
